Please login to the form below

Not currently logged in
Email:
Password:

inVentiv invests in virtual trials

Acquires equity stake in US-based Mytrus

Contract research organisation (CRO) inVentiv Health Clinical has acquired an equity stake in US-based 'virtual clinical trials' firm Mytrus.

Mytrus, which was founded in 2009, has been developing FDA-approved technology that enables people to participate in clinical trials remotely.

While full details of the agreement were not disclosed, inVentiv Health stated that as well as acquiring "significant equity stakes" in Mytrus, it has also established a "strategic commercial relationship" with the firm.

"This partnership blends our shared drive for innovation and our complementary experience from the world of high tech and clinical research," said Paul Meister, CEO of inVentiv Health.

"The goal is improved trial execution, accelerated time to market and reduced product development costs for our clients."

Providing they meet the eligibility requirements, participants can submit their data from anywhere, which can both lower campaign costs and improve stakeholder convenience.

"Reducing the overall cost of clinical trials and increasing patient recruitment remain serious issues for sponsors," explained Ray Hill, president of inVentiv Health Clinical.

"Our partnership with Mytrus will allow us to recruit and retain a broader base of patients more quickly to help meet our clients' needs."

Mytrus was brought to public attention in 2011 when it helped Pfizer launch the pharma company's Remote trials for the overactive bladder drug Detrol LA (tolterodine tartrate).

The trial was ultimately shelved due to a disappointing "rate of on-line patient recruitment", however, Pfizer vowed to continue to use social media and the internet to boost patient recruitment rates in its clinical trials, despite the failure of the pilot.

20th March 2013

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics